CMTM6 drives cisplatin resistance in OSCC by regulating AKT mediated Wnt signaling
P. Mohapatra, O. Shriwas, S. Mohanty, S. R. Kaushik, R. Arya, R. Rath, S. Das Majumdar, D. Muduly, R. K. Nanda, R. Dash
This study identifies CMTM6 as a driver of cisplatin resistance in OSCC by activating AKT-mediated Wnt signaling, leading to increased survival gene expression and tumor growth.
bioRxiv · Mar 18, 2020Cancer Biology